Actym Therapeutics(@ActymT), based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer.
— Sachs Associates (@SachsAssociates) May 6, 2022
e-Meet Prescient Therapeutics at #Sachs_IOIF
More info @ https://t.co/08rXthnHxk pic.twitter.com/YShk4NkfLn